Search results for: “Macular degeneration”
-
Study Indicates AMD Patients are at Higher Risk of COVID-19 Complications
A study conducted at New York Presbyterian/Columbia University Irving Medical Center, and published in Nature Medicine, indicates that patients with macular degeneration are at higher risk of complications due to COVID-19. The study, entitled “Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection,” looked at 6,398 COVID patients during the first wave of
-
AMDF 2020 Year-In-Review and What’s Coming Up in 2021
2020. What a challenging year! Here at AMDF, our tight-knit team switched from regular, in-person meetings to a year of working remotely and, yes, using Zoom! Perhaps you have also discovered this, but, somehow, that break from our usual routines inspired us to think outside the box. Here are the highlights of 2020: COVID-19 Response
-
Weight Reduction Can Decrease Risk of Late AMD
If you’re looking to improve your eye health, losing weight might be a good place to start. While it’s not a guaranteed cure for age-related macular degeneration (AMD), studies suggest that excess weight, especially around the waist, can increase your risk of developing advanced forms of AMD. What the Research Says A 2003 study by
-
Raise Awareness
We look forward to the day that awareness of macular degeneration is as common as other major conditions, such as diabetes, or heart disease. Other than the juvenile form of macular degeneration (Stargardt’s), macular degeneration has several known modifiable risk factors. If you knew you could save your sight for longer, wouldn’t you want the
-
AMDF Advocacy
The American Macular Degeneration Foundation is working toward securing access to the treatments, tools, and services that preserve vision and independence for all Americans with macular degeneration. Through our advocacy, we fight for you, and with you. We fight for your right to affordable treatments, tools, services, and technology, and your right to transportation access.
-
What We Do
We are a small, but highly impactful organization, driven by passion to empower patients with macular degeneration by: Funding Critical Macular Degeneration Research More than anything else, people diagnosed with macular degeneration long for a cure. While cures for diseases as complex as macular degeneration can be elusive, research over the last few decades has
-
Our Story
AMDF was established in 1993, shortly after our founder, Chip Goehring, was diagnosed at the age of 39 with macular degeneration. He was told he was going to go blind, and yet found a dearth of information available to macular degeneration patients. AMDF was born out of Chip’s drive to find answers for the devastating
-
Research Advancements
The Complement Factors in Age-related Macular DegenerationAn Interview with Gregory Hageman, PhD
-
AMDF Research Grant Descriptions
This page offers descriptions of the grants The American Macular Degeneration Foundation awards annually to support foundational and cutting edge macular degeneration research. Please note that grant amounts vary depending on proposed scope of work/ project duration, as well as the availability of funding resources. AMDF Breakthrough Award Intended to advance a previously unfunded investigation
-
Past Research Grants
*This section is still under construction and does not represent the full list 2022 AMDF Research Grants AMDF Breakthrough Award (for Stargardt’s) To Martin-Paul Agbaga, PhD, Assistant Professor, Department of Ophthalmology, University of Oklahoma Health Sciences Center, to optimize and create methods for efficient delivery of very long chain polyunsaturated fatty acids to the retina,